Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

Upon completion of this CME activity, participants should be able to:

• The participant will develop a better understanding of the potential role of gene and viral therapies for glioblastoma treatment.
• The participant will develop a greater knowledge of targets for gene therapy and viral vectors used for glioblastoma treatment.
• The participant will learn about the methods for gene and viral therapy delivery.
• The participant will gain a greater understanding and appreciation of the clinical trial designs and safety issues around gene and viral therapy in neurosurgical neuro-oncology.